/**/ RNS Number : 2817G IQ-AI Limited 25 April 2025   IQ-AI Ltd (“IQ-AI” or “the Company”) Publication of Annual Report   The Board of IQ-AI Ltd is pleased to announce the Company’s audited financial statements for the year ended 31 December 2024.   The Annual Report will be available on the Company’s corporate website

/**/ RNS Number : 7655E IQ-AI Limited 11 April 2025   IQ-AI Ltd (“IQ-AI” or the “Company”) Imaging Biometrics Announces Promising Preliminary Results of Phase 1 Study   Oral Gallium Maltolate Demonstrates Early Signals of Efficacy   IQ-AI is pleased to provide the following update on its wholly-owned subsidiary, Imaging Biometrics LLC. The study on

/**/ RNS Number : 1361B IQ-AI Limited 18 March 2025   IQ-AI Ltd (“IQ-AI” or the “Company”)   Placing to raise £250,000   IQ-AI is pleased to announce that that the Company, through its corporate broker Peterhouse Capital Limited (“Peterhouse”), has conditionally raised gross proceeds of £250,000 via a placing (the “Placing”) of 25,000,000 new

/**/ RNS Number : 5554V IQ-AI Limited 03 February 2025   February 3, 2025   Imaging Biometrics Expands Distribution with Blackford   Imaging Biometrics, LLC (IB), Elm Grove, WI, a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI), has amended their existing distribution agreement with AI platform provider Blackford Analysis Ltd (Blackford). The amendment adds

/**/ RNS Number : 1961U IQ-AI Limited 22 January 2025   IQ-AI Ltd (“IQ-AI” or the “Company”)   Operations Update   IQ-AI is pleased to announce an operations update. In this update, we focus on the relevance of artificial intelligence (“AI”) to our business, describe ongoing product development utilising AI in 2025, and provide an

/**/ RNS Number : 8964S IQ-AI Limited 10 January 2025   IQ-AI Ltd ​ (“IQ-AI” or the “Company”)   Imaging Biometrics and Prism Clinical Imaging Secure First Installation   The combined technologies will enhance neurosurgical planning and treatment strategies      Imaging Biometrics (IB), a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI), is pleased

/**/ RNS Number : 8473M IQ-AI Limited 20 November 2024   November 20, 2024 IQ-AI Ltd (“IQ-AI” or the “Company”) Imaging Biometrics Expands Distribution   Imaging Biometrics (IB), Elm Grove, WI, a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI) has renewed its distribution agreement with GE HealthCare. This agreement aims to expand the distribution

/**/ RNS Number : 8206M IQ-AI Limited 19 November 2024   IQ-AI Ltd (“IQ-AI” or the “Company”)   Board Changes   IQ-AI Appoints Renowned Brain Tumor Champion to Board of Directors     IQ-AI Ltd (LSE: IQAI) is pleased to announce the appointment of Dr. Al Musella, MD, as a Non-Execuitve Director. Dr. Musella brings

/**/ RNS Number : 8681K IQ-AI Limited 05 November 2024   November 5, 2024 IQ-AI Ltd (“IQ-AI” or the “Company”)   New Patent Application, Trading Update and Commencement of discussions with potential phase 2 partners   IQ-AI (LSE: IQAI) Imaging Biometrics (“IB”) has filed a provisional patent application with the United States Patent and Trademark

/**/ RNS Number : 2550I IQ-AI Limited 15 October 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or the underlying issuer of existing shares to which